Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01949532
What this trial is testing

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease

Who this might be right for
Relapsed Multiple MyelomaEnd-stage Renal Disease
Amgen 26
Post-approval studies (Phase 4)Study completedNCT01704001
What this trial is testing

Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment

Who this might be right for
Disseminated Intravascular Coagulation
Asahi Kasei Therapeutics Corporation 40
Testing effectiveness (Phase 2)Study completedNCT00110929
What this trial is testing

Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)

Who this might be right for
End Stage Renal Disease
Amgen 850
Early research (Phase 1)Ended earlyNCT03241147
What this trial is testing

Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment

Who this might be right for
Renal Failure
H. Lundbeck A/S 23
Early research (Phase 1)Study completedNCT06698549
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function

Who this might be right for
COVID 19
Aligos Therapeutics 12
Early research (Phase 1)Study completedNCT01619033
What this trial is testing

Pharmacokinetics of BF2.649 in Renal Impairment

Who this might be right for
Renal Impairment
Bioprojet 25
Early research (Phase 1)Study completedNCT01323855
What this trial is testing

Assess Pharmacokinetics (PK) of Preladenant in Participants With Chronic Renal Impairment (CRI) (P06512)

Who this might be right for
Parkinson Disease
Merck Sharp & Dohme LLC 46
Early research (Phase 1)Study completedNCT04865393
What this trial is testing

Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function

Who this might be right for
Renal Impairment
Spero Therapeutics 37
Early research (Phase 1)Study completedNCT04178447
What this trial is testing

Pharmacokinetic Profile of Glepaglutide After a Single Injection in Subjects With Varying Degrees of Renal Function

Who this might be right for
Renal Impairment
Zealand Pharma 16
Early research (Phase 1)Study completedNCT06468826
What this trial is testing

Avacopan in Participants With Normal Renal Function and Participants With End-Stage Renal Disease (ESRD)

Who this might be right for
End-Stage Renal Disease (ESRD)
Amgen 13
Early research (Phase 1)Study completedNCT01613690
What this trial is testing

Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal Impairment

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 48
Post-approval studies (Phase 4)Active Not RecruitingNCT00725127
What this trial is testing

Chronotherapy with Low-dose Aspirin for Primary Prevention

Who this might be right for
Type 2 Diabetes
University of Vigo 3,200
Testing effectiveness (Phase 2)Study completedNCT04707573
What this trial is testing

Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Participants With Chronic Kidney Disease (CKD), Stages 3 and 4

Who this might be right for
Chronic Kidney Disease
Akebia Therapeutics 22
Early research (Phase 1)Study completedNCT02219516
What this trial is testing

Mild, Moderate and Severe Renal Impairment Study

Who this might be right for
Gout
Ardea Biosciences, Inc. 31
Early research (Phase 1)Study completedNCT05497297
What this trial is testing

Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Haisco Pharmaceutical Group Co., Ltd. 42
Early research (Phase 1)Not Yet RecruitingNCT07797322
What this trial is testing

Investigate the Pharmacokinetics and Safety of PKN605 in Participants With Moderate and Severe Renal Impairment Compared to Matched Control Subjects With Normal Renal Function

Who this might be right for
Participants With Moderate and Severe Renal Impairment and Healthy Participants
Novartis Pharmaceuticals 40
Large-scale testing (Phase 3)Ended earlyNCT00156962
What this trial is testing

Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Disease
Amgen 850
Early research (Phase 1)Study completedNCT04142970
What this trial is testing

Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions

Who this might be right for
Chronic Renal Impairment
Sichuan Haisco Pharmaceutical Group Co., Ltd 24
Early research (Phase 1)Study completedNCT01131845
What this trial is testing

The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil

Who this might be right for
Pulmonary Arterial HypertensionRenal Dysfunction
United Therapeutics 16
Large-scale testing (Phase 3)Study completedNCT00240331
What this trial is testing

AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)

Who this might be right for
Renal Failure
AstraZeneca 2,776
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation